Fernando A. Rivera

The Safety of Electroconvulsive Therapy in Patients With Prolonged QTc Intervals on the Electrocardiogram

P. Mueller, K. Rasmussen, S. J. Pullen, 2011, The journal of ECT.

Depression: A Modifiable Risk Factor for Poor Outcomes in Fibromyalgia

D. Hodge, A. A. Abu Dabrh, A. Abril, 2022, Journal of primary care & community health.

Intensive Multicomponent Fibromyalgia Treatment

T. Rummans, S. Hines, A. Abril, 2020, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Physician Satisfaction With Telemedicine During the COVID-19 Pandemic: The Mayo Clinic Florida Experience

M. Heckman, A. A. Abu Dabrh, D. Trifiletti, 2021, Mayo Clinic Proceedings: Innovations, Quality & Outcomes.

Association of Vitamin B12, Vitamin D, and Thyroid-Stimulating Hormone With Fatigue and Neurologic Symptoms in Patients With Fibromyalgia

A. A. Abu Dabrh, N. Dawson, P. Malavet, 2022, Mayo Clinic proceedings. Innovations, quality & outcomes.

Safety of Electroconvulsive Therapy in Patients With a History of Heart Failure and Decreased Left Ventricular Systolic Heart Function

S. Sampson, P. Mueller, M. Lapid, 2011, The journal of ECT.

Opioid Use in Fibromyalgia Continues Despite Guidelines That Do Not Support Its Efficacy or Risk

Lisa M. Nordan, L. White, A. Abril, 2020, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobile spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities

T. Rozen, D. Fairweather, B. Bruce, 2023, Frontiers in Medicine.

A retrospective analysis of the prevalence and impact of associated comorbidities on fibromyalgia outcomes in a tertiary care center

Mikolaj Wieczorek, Madeleine Allman, Fernando A. Rivera, 2024, Frontiers in medicine.